Sort
51,593 grants matching “hepatitis”
Photoabsorbing bioinks for expanding 3D printed human liver in situ
$683,694Kelly R Stevens · University Of Washington · R01 · FY2024 · DK
Risk Factors for AIDS Among Intravenous Drug Users
$683,636Don C Des Jarlais · Beth Israel Medical Ctr (New York) · R01 · FY2007 · DA
Studies of Inherited Causes of Fungal Susceptability
$683,551Sergio Rosenzweig · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes
$683,486Sudha B Biddinger · Boston Children'S Hospital · R01 · FY2023 · HL
Accelerating Wound Healing through RNAi
$683,474Brian H. Johnston · Somagenics, Inc. · R44 · FY2015 · GM
Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis
$683,378Mariana Lazo Elizondo · Drexel University · R01 · FY2023 · DK
OVARIAN CANCER RISK AND HYPERGONADOTROPIC HYPOGONADISM
$683,370Brigham And Women'S Hospital · R01 · FY2001 · CA
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness
$683,339Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
A systematic analysis of small RNA interactions during RNA virus infections
$683,339Charles M. Rice · Rockefeller University · R01 · FY2019 · AI
Combating Chronic Liver Diseases via Understanding and Engineering Cell Competition and Fitness
$683,339Michael Oertel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Rhesus HHV-8 homologue in AIDS-related malignancies
$683,330Scott W Wong · Oregon Health & Science University · R01 · FY2020 · CA
HIV Disease Outcomes in Drug Users in Clinical Practice
$683,258Richard Douglas Moore · Johns Hopkins University · R01 · FY2012 · DA
Development of FAPI PET as a Non-invasive Biomarker of Liver Fibrogenesis
$683,258Ali Pirasteh · University Of Wisconsin-Madison · R01 · FY2024 · DK
MECHANISMS OF CHRONIC HEPATITIS B INFECTION
$683,213Vaccine Research Institute Of San Diego · R01 · FY2004 · AI
Mechanisms of Insulin Resistance in Man
$683,211Rita Basu · University Of Virginia · R01 · FY2020 · DK
Countermeasures Against Chemical Threats: Countermeasures Against Cyanide
$683,171Steven E Patterson · University Of Minnesota · U01 · FY2008 · NS
Integrative Polygenic Genetic Studies of Non-alcoholic Fatty Liver Disease
$683,142Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2023 · DK
Development and Validation of Prognostic Radiomic Markers of Response and Recurrence for Patients with Colorectal Liver Metastases
$683,138Richard Kinh Gian Do · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
STD and AIDS Research Training Grant
$683,137Anna Wald · University Of Washington · T32 · FY2020 · AI
Molecular Prognostic Indicators in Liver Cirrhosis and Cancer
$683,136Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · DK
Molecular Prognostic Indicators in Liver Cirrhosis and Cancer
$683,136Yujin Hoshida · Icahn School Of Medicine At Mount Sinai · R01 · FY2015 · DK
Inflammatory response to sleep apnea in obese subjects
$683,045Frederick F Samaha · University Of Pennsylvania · R01 · FY2007 · HL
Towards Evidence-Based Monitoring of Low Dose Methotrexate: CIRT Ancillary Study
$682,979Daniel Hal Solomon · Brigham And Women'S Hospital · R01 · FY2015 · HL
HIV, HCV and the Menopausal Transition: Effects on Steatosis and Fibrosis Progression
$682,950Phyllis C Tien · Northern California Institute/Res/Edu · R01 · FY2020 · DK
In vivo HTS assay for novel modulators of Apolipoprotein B
$682,895Steven A Farber · Carnegie Institution Of Washington, D.C. · R01 · FY2018 · DK